Almaty, Kazakhstan - On January 23-24, 2025, the second International Gastroenterology Conference "Almaty Gastro" was successfully held in Almaty, the largest city in Kazakhstan. This conference brought together gastroenterology experts, scholars, and industry representatives from Kazakhstan, Russia, and neighboring countries to explore the theoretical frontiers and clinical practices of modern gastroenterology and hepatology. On the first day of the conference, it was held at the "Bakshasaray Banquet Hall" at 42 Timiryazev Street, Almaty City. The next day, a master class seminar was held at "Private Clinic Almaty".

It is worth noting that several leading Chinese medical technology companies deeply participated in this academic event, bringing the latest technologies and solutions in the detection, diagnosis, and treatment of Helicobacter pylori (H. pylori), which became the focus of attention at the venue.

Chinese innovative products attract attention

At the conference exhibition area, Shenzhen Zhonghe Headway Bio Sci&Tech Co., Ltd. showcased its advanced "H. pylori&urea breath test" detection solution. This product provides an important tool for non-invasive diagnosis of Helicobacter pylori with its high precision and reliability, and has received extensive consultation and praise from attending experts.

In addition, the latest achievements of Chinese companies in the field of acid suppression therapy have also become a hot topic of discussion. Tai Xinzan was introduced at the meeting ® Tegopazan is a novel acid suppressing drug (P-CABs). As a potassium ion competitive acid blocker, it provides a new drug option for acid suppression in the eradication treatment of Helicobacter pylori, and its clinical advantages and data have attracted in-depth exploration by multiple experts.

Focus on the prevention and treatment of Helicobacter pylori

In the academic discussion session, the prevention and treatment of Helicobacter pylori became one of the core topics. Experts once again emphasized the consensus of the World Health Organization (WHO) in 1994 to classify Helicobacter pylori as a Group I carcinogen, and delved into its close association with various gastrointestinal diseases such as chronic gastritis, peptic ulcers, and gastric cancer. The integrated solutions provided by Chinese enterprises in the above-mentioned fields, from precise diagnosis to innovative treatment, have contributed "Chinese wisdom" and "Chinese solutions" to the local response to this public health challenge.

Promote medical cooperation between China and Kazakhstan

This conference is not only a platform for academic exchange, but also creates a good opportunity for deepening cooperation between China and Kazakhstan in the field of healthcare. The active participation and technology display of Chinese enterprises reflect the efforts and strength of Chinese medical technology enterprises to "go global", actively participate in international academic dialogues, and contribute to the construction of the "Healthy Silk Road".

Through this meeting, medical professionals from China and Kazakhstan have enhanced their understanding, laying a solid foundation for further cooperation in clinical research, technology introduction, and talent cultivation in the future.

At the Almaty International Gastroenterology Conference, the top four countries of 'China Uyghur Khaganate' 🔝 Chief gastroenterologist, endorsing the "breath diagnostic Hp test" for "CNNC Haidewei Biotechnology Co., Ltd.":

1. Professor Zhong Liaoyuan, Chief Physician of Gastroenterology at Xiangya Hospital Zhuzhou Affiliated Hospital of Central South University

2. President of the Uzbekistan Gastrointestinal Society, Doctor of Medicine: Karimov Malwast Malwaskovich

3. Chief Gastrointestinal Expert in Almaty, Kazakhstan, and Chairman of the Kazakhstan Gastrointestinal Society: Isgagov Bawuleran Samikuovi ć

4. President of the Gastrointestinal Society, Doctor of Medicine: Mamraimo Nanebayevich